The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
SAH derived potent and selective EZH2 inhibitors.EBI
Pfizer
Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.EBI
University of North Carolina At Chapel Hill
Exploiting an allosteric binding site of PRMT3 yields potent and selective inhibitors.EBI
University of North Carolina At Chapel Hill
Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2.EBI
TBA
Optimization of cellular activity of G9a inhibitors 7-aminoalkoxy-quinazolines.EBI
University of North Carolina At Chapel Hill
New small molecule inhibitors of histone methyl transferase DOT1L with a nitrile as a non-traditional replacement for heavy halogen atoms.EBI
University College London